Agios Pharmaceuticals is a startup based in the United States, 1 tracked investor.
Agios Pharmaceuticals is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Agios Pharmaceuticals is a publicly traded biopharmaceutical company that discovers and develops investigational medicines to treat cancer and rare genetic diseases, with scientific expertise in cellular metabolism. The company has multiple clinical and preclinical programs and has brought oncology precision medicines to market.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.